Cargando…
Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic acid (VPA) in children with epilepsy. However, the predictive performance of these models in the extrapolation to other clinical environments has not been studied. Hence, this study evaluated the predic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587682/ https://www.ncbi.nlm.nih.gov/pubmed/37869748 http://dx.doi.org/10.3389/fphar.2023.1228641 |
_version_ | 1785123420384526336 |
---|---|
author | Zhang, Lina Liu, Maochang Qin, Weiwei Shi, Dandan Mao, Junjun Li, Zeyun |
author_facet | Zhang, Lina Liu, Maochang Qin, Weiwei Shi, Dandan Mao, Junjun Li, Zeyun |
author_sort | Zhang, Lina |
collection | PubMed |
description | Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic acid (VPA) in children with epilepsy. However, the predictive performance of these models in the extrapolation to other clinical environments has not been studied. Hence, this study evaluated the predictive abilities of pediatric popPK models of VPA and identified the potential effects of protein binding modeling strategies. Methods: A dataset of 255 trough concentrations in 202 children with epilepsy was analyzed to assess the predictive performance of qualified models, following literature review. The evaluation of external predictive ability was conducted by prediction- and simulation-based diagnostics as well as Bayesian forecasting. Furthermore, five popPK models with different protein binding modeling strategies were developed to investigate the discrepancy among the one-binding site model, Langmuir equation, dose-dependent maximum effect model, linear non-saturable binding equation and the simple exponent model on model predictive ability. Results: Ten popPK models were identified in the literature. Co-medication, body weight, daily dose, and age were the four most commonly involved covariates influencing VPA clearance. The model proposed by Serrano et al. showed the best performance with a median prediction error (MDPE) of 1.40%, median absolute prediction error (MAPE) of 17.38%, and percentages of PE within 20% (F(20), 55.69%) and 30% (F(30), 76.47%). However, all models performed inadequately in terms of the simulation-based normalized prediction distribution error, indicating unsatisfactory normality. Bayesian forecasting enhanced predictive performance, as prior observations were available. More prior observations are needed for model predictability to reach a stable state. The linear non-saturable binding equation had a higher predictive value than other protein binding models. Conclusion: The predictive abilities of most popPK models of VPA in children with epilepsy were unsatisfactory. The linear non-saturable binding equation is more suitable for modeling non-linearity. Moreover, Bayesian forecasting with prior observations improved model fitness. |
format | Online Article Text |
id | pubmed-10587682 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105876822023-10-21 Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study Zhang, Lina Liu, Maochang Qin, Weiwei Shi, Dandan Mao, Junjun Li, Zeyun Front Pharmacol Pharmacology Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic acid (VPA) in children with epilepsy. However, the predictive performance of these models in the extrapolation to other clinical environments has not been studied. Hence, this study evaluated the predictive abilities of pediatric popPK models of VPA and identified the potential effects of protein binding modeling strategies. Methods: A dataset of 255 trough concentrations in 202 children with epilepsy was analyzed to assess the predictive performance of qualified models, following literature review. The evaluation of external predictive ability was conducted by prediction- and simulation-based diagnostics as well as Bayesian forecasting. Furthermore, five popPK models with different protein binding modeling strategies were developed to investigate the discrepancy among the one-binding site model, Langmuir equation, dose-dependent maximum effect model, linear non-saturable binding equation and the simple exponent model on model predictive ability. Results: Ten popPK models were identified in the literature. Co-medication, body weight, daily dose, and age were the four most commonly involved covariates influencing VPA clearance. The model proposed by Serrano et al. showed the best performance with a median prediction error (MDPE) of 1.40%, median absolute prediction error (MAPE) of 17.38%, and percentages of PE within 20% (F(20), 55.69%) and 30% (F(30), 76.47%). However, all models performed inadequately in terms of the simulation-based normalized prediction distribution error, indicating unsatisfactory normality. Bayesian forecasting enhanced predictive performance, as prior observations were available. More prior observations are needed for model predictability to reach a stable state. The linear non-saturable binding equation had a higher predictive value than other protein binding models. Conclusion: The predictive abilities of most popPK models of VPA in children with epilepsy were unsatisfactory. The linear non-saturable binding equation is more suitable for modeling non-linearity. Moreover, Bayesian forecasting with prior observations improved model fitness. Frontiers Media S.A. 2023-10-06 /pmc/articles/PMC10587682/ /pubmed/37869748 http://dx.doi.org/10.3389/fphar.2023.1228641 Text en Copyright © 2023 Zhang, Liu, Qin, Shi, Mao and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhang, Lina Liu, Maochang Qin, Weiwei Shi, Dandan Mao, Junjun Li, Zeyun Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study |
title | Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study |
title_full | Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study |
title_fullStr | Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study |
title_full_unstemmed | Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study |
title_short | Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study |
title_sort | modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587682/ https://www.ncbi.nlm.nih.gov/pubmed/37869748 http://dx.doi.org/10.3389/fphar.2023.1228641 |
work_keys_str_mv | AT zhanglina modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy AT liumaochang modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy AT qinweiwei modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy AT shidandan modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy AT maojunjun modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy AT lizeyun modelingtheproteinbindingnonlinearityinpopulationpharmacokineticmodelofvalproicacidinchildrenwithepilepsyasystematicevaluationstudy |